secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2024-03-06T23:59:59+00:00
Accession:  0001493152-24-009028
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Hepion appoints Michael Purcell to board as Audit Committee Chair
-----------------------------------------------------------------

- Michael Purcell appointed as director of Hepion Pharmaceuticals on March 5, 2024.
- Purcell named Chair of Audit Committee and member of Compensation and Corporate Governance/Nominations Committees.
- No departures reported; Purcell fills a board vacancy.
- Appointment effective immediately upon board vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315224009028/0001493152-24-009028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315224009028/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer